It also happens in the very real, flesh and blood of academic medicine. So in 1980, some researchers did a study on a drug called lorcainide, and this was an anti-arrhythmic drug, a drug that suppresses abnormal heart rhythms, and the idea was, after people have had a heart attack, they're quite likely to have abnormal heart rhythms, so if we give them a drug that suppresses abnormal heart rhythms, this will increase the chances of them surviving.
Det sker også i virkeligheden, i kød og blod indenfor lægevidenskaben. Så i 1980 udførte nogle forskere et studie om en medicin kaldet lorcainide, som var et middel mod hjerteflimmer, et lægemiddel som undertrykker unormale hjerterytmer, og ideen var at folk som havde haft et hjerteanfald, de har ofte også unormale hjerterytme, så hvis man gav dem et middel som dæmpede unormal hjerterytmer, så ville det forøge deres chancer  for at overleve.